Biosimilar Approval: How FDA Reviews Biologic Alternatives in 2026
The FDA's 2025 update to biosimilar approval rules cuts development time and costs, making life-saving biologic alternatives more accessible. Learn how modern science is changing how these complex drugs are reviewed-and why patients stand to save billions.